NCF DIAGNOSTICS & DNA TECHNOLOGIES Trademark

Trademark Overview

On Friday, August 31, 2018, a trademark application was filed for NCF DIAGNOSTICS & DNA TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the NCF DIAGNOSTICS & DNA TECHNOLOGIES trademark a serial number of 88100572. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2019. This trademark is owned by NORTH CENTRAL FLORIDA NEURODIAGNOSTIC SERVICES LIMITED LIABILITY COMPANY. The NCF DIAGNOSTICS & DNA TECHNOLOGIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical laboratory services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific laboratory services
ncf diagnostics & dna technologies

General Information

Serial Number88100572
Word MarkNCF DIAGNOSTICS & DNA TECHNOLOGIES
Filing DateFriday, August 31, 2018
Status700 - REGISTERED
Status DateTuesday, July 9, 2019
Registration Number5797876
Registration DateTuesday, July 9, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Description of MarkThe mark consists of the letters "NFC" in dark blue with a design of a double helix inside a circle, with half of it being aqua and half being dark blue, to the left, and to the right of "NFC" is a gray vertical line followed by the words "DIAGNOSTICS & DNA TECHNOLOGIES" in gray.
Pseudo MarkNORTH CENTRAL FLORIDA DIAGNOSTICS AND DNA TECHNOLOGIES
Indication of Colors claimedThe color(s) aqua, navy blue, and gray is/are claimed as a feature of the mark.
NOT AVAILABLE"DIAGNOSTICS & DNA TECHNOLOGIES"
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical laboratory services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific laboratory services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 10, 2018
Primary Code042
First Use Anywhere DateThursday, March 2, 2017
First Use In Commerce DateThursday, March 2, 2017

Trademark Owner History

Party NameNORTH CENTRAL FLORIDA NEURODIAGNOSTIC SERVICES LIMITED LIABILITY COMPANY
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615
Party NameNORTH CENTRAL FLORIDA NEURODIAGNOSTIC SERVICES LIMITED LIABILITY COMPANY
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615
Party NameNORTH CENTRAL FLORIDA NEURODIAGNOSTIC SERVICES LIMITED LIABILITY COMPANY
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615

Trademark Events

Event DateEvent Description
Thursday, December 13, 2018ASSIGNED TO EXAMINER
Tuesday, September 4, 2018NEW APPLICATION ENTERED
Monday, September 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 11, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, December 14, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, December 14, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, December 14, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, December 14, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, December 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 2, 2019FINAL REFUSAL WRITTEN
Wednesday, January 2, 2019FINAL REFUSAL E-MAILED
Wednesday, January 2, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 16, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, January 20, 2019ASSIGNED TO LIE
Monday, January 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 1, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 1, 2019WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Friday, February 1, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, February 1, 2019EXAMINERS AMENDMENT E-MAILED
Friday, February 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 1, 2019EXAMINER'S AMENDMENT ENTERED
Friday, February 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 4, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 5, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, February 6, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 19, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, February 27, 2019ASSIGNED TO PETITION STAFF
Friday, March 1, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, March 4, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 14, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, March 21, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 14, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, March 14, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

technologies diagnostics services laboratory research expression gene field scientific namely cancer providing